Retraction Note: Evaluation of the anticancer potential of CD44 targeted vincristine nanoformulation in prostate cancer xenograft model: a multi-dynamic approach for advanced pharmacokinetic evaluation

Abstract

Retraction Note: Cancer Nanotechnology (2023) 14:65 https://doi.org/10.1186/s12645-023-00218-2

The Editors-in-Chief have retracted this article. After publication, concerns were raised regarding some of the images presented in the figures, specifically:

• Fig. 6 appears highly similar to Fig. 10 of Naseer et al. (2023)

• Fig. 6 Pure VC 12 h 90 ug/ml and VC-loaded TCs-HA 24 h 50 ug/ml images appear highly similar

• Fig. 17 A5 and Fig. 18 D5 images appear to overlap (flipped and with different magnification)

• Fig. 18 C6 and D6 appear to overlap (with different magnification)

• Several panels in Figs. 17 and 18 appear highly similar to those in Fig. 8 of Kousar et al. (2023)

The authors have been unable to provide the underlying raw data upon request. The Editors-in-Chief therefore no longer have confidence in the presented data.

None of the authors have responded to any correspondence from the editor or publisher about this retraction notice.

• Naseer F, Ahmad T, Kousar K, Kakar S, Gul R, Anjum S, Shareef U (2023) Formulation for the targeted delivery of a vaccine strain of oncolytic measles virus (OMV) in hyaluronic acid coated thiolated chitosan as a green nanoformulation for the treatment of prostate cancer: a viro-immunotherapeutic approach. Int J Nanomed 18:185–205. https://doi.org/10.2147/IJN.S386560

  Article CAS Google Scholar

• Kousar K, Naseer F, Abduh MS et al (2023) Green synthesis of oncolytic Newcastle disease virus-loaded thiolated chitosan nanoformulation for CD44 targeted delivery and sustained release of virus in cervical cancer xenografts. Cancer Nano 14:71. https://doi.org/10.1186/s12645-023-00220-8

  Article CAS Google Scholar

Download references

Authors and Affiliations

1. Industrial Biotechnology, Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan

   Faiza Naseer, Kousain Kousar & Tahir Ahmad

2. Shifa College of Pharmaceutical Sciences, Shifa Tameer e Millat University, Islamabad, Pakistan

   Faiza Naseer

3. Immune Responses in Different Diseases Research Group, Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdul-Aziz University, 21589, Jeddah, Saudi Arabia

   Maisa S. Abduh

4. Department of Biology, University of Hail, Hail, Saudi Arabia

   Sadia Anjum

Authors

1. Faiza NaseerView author publications

   You can also search for this author in PubMed Google Scholar

2. Kousain KousarView author publications

   You can also search for this author in PubMed Google Scholar

3. Maisa S. AbduhView author publications

   You can also search for this author in PubMed Google Scholar

4. Sadia AnjumView author publications

   You can also search for this author in PubMed Google Scholar

5. Tahir AhmadView author publications

   You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Faiza Naseer or Tahir Ahmad.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Cite this article

Naseer, F., Kousar, K., Abduh, M.S. et al. Retraction Note: Evaluation of the anticancer potential of CD44 targeted vincristine nanoformulation in prostate cancer xenograft model: a multi-dynamic approach for advanced pharmacokinetic evaluation. Cancer Nano 15, 39 (2024). https://doi.org/10.1186/s12645-024-00278-y

Download citation

• Published: 27 July 2024

• DOI: https://doi.org/10.1186/s12645-024-00278-y

Share this article

Anyone you share the following link with will be able to read this content:

Get shareable link

Sorry, a shareable link is not currently available for this article.

Copy to clipboard

Provided by the Springer Nature SharedIt content-sharing initiative